|
Volumn 7, Issue 3, 2010, Pages 234-
|
Augmentation therapy for Alpha-1 antitrypsin deficiency - Not enough evidence to support its use yet!
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AIRWAY OBSTRUCTION;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COST EFFECTIVENESS ANALYSIS;
COST OF ILLNESS;
DENSITOMETRY;
EVIDENCE BASED PRACTICE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LETTER;
LUNG FUNCTION;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
ALPHA 1-ANTITRYPSIN DEFICIENCY;
COMPLICATION;
DRUG EFFECTS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
TREATMENT OUTCOME;
ALPHA 1-ANTITRYPSIN;
ALPHA 1-ANTITRYPSIN DEFICIENCY;
FORCED EXPIRATORY VOLUME;
HUMANS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
TREATMENT OUTCOME;
TRYPSIN INHIBITORS;
ALPHA 1 ANTITRYPSIN;
TRYPSIN INHIBITOR;
|
EID: 77952806527
PISSN: 15412555
EISSN: 15412563
Source Type: Journal
DOI: 10.3109/15412555.2010.485108 Document Type: Letter |
Times cited : (9)
|
References (6)
|